Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 08, 2023

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open

 

Additional Info

JAMA Network Open
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
JAMA Netw Open 2023 Apr 26;6(4)e2310039, RA Bender Ignacio, KW Chew, C Moser, JS Currier, JJ Eron, AC Javan, MJ Giganti, E Aga, M Gibbs, H Tchouakam Kouekam, E Johnsson, MT Esser, K Hoover, G Neytman, M Newell, ES Daar, W Fischer, CV Fletcher, JZ Li, AL Greninger, RW Coombs, MD Hughes, D Smith, DA Wohl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading